GENOPHAR: a randomized study of plasma drug measurements in association with genotypic resistance testing and expert advice to optimize therapy in patients failing antiretroviral therapy.
about
Therapeutic drug monitoring of antiretrovirals for people with HIVPlasma concentrations of efavirenz and nevirapine among HIV-infected patients with immunological failure attending a tertiary hospital in North-western TanzaniaA randomized trial of therapeutic drug monitoring of protease inhibitors in antiretroviral-experienced, HIV-1-infected patients.Antiretroviral therapeutic drug monitoring in Canada: current status and recommendations for clinical practiceBenefit of therapeutic drug monitoring of protease inhibitors in HIV-infected patients depends on PI used in HAART regimen--ANRS 111 trialQuality assessment for therapeutic drug monitoring in AIDS Clinical Trials Group (ACTG 5146): a multicenter clinical trial.Role of the Pharmacist in Caring for Patients with HIV/AIDS: Clinical Practice Guidelines.Practical therapeutic drug management in HIV-infected patients: use of population pharmacokinetic models supplemented by individualized Bayesian dose optimizationTherapeutic drug monitoring in highly active antiretroviral therapy.Therapeutic drug monitoring of antiretroviral drugs in HIV-infected patients.Minimum effective plasma concentration of efavirenz in treatment-naïve Chinese HIV-infected patients.British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy (2005).
P2860
Q24239932-004DD4C0-FA2B-4A6D-84C6-EE0CCC0C5C59Q28533168-A4E3A45E-0B9B-416B-AAD5-5D9BF669597BQ33559216-BE13D092-22E3-4D51-9403-82B65226DC99Q33681426-1A6A25FB-F332-4C0B-B627-C882C01B3960Q34103495-CB3B5105-A3B6-4760-A116-75AB4F6B6CE7Q34114808-ADE26623-8660-41C9-ADD7-FED134C565DAQ35898538-9596B121-3FAD-4EED-8A3E-C32C77AC5D4AQ37298637-FE353FD6-83F3-4484-A89C-405FF7B30C1CQ37720765-E664F864-03BF-4C7D-A563-55C9AD1B7A78Q38954109-67F11ADB-93FF-4F42-862F-9A7C9C0A4E8BQ42752406-AD5B1B58-89D5-422E-B709-9C67D59232C2Q53851252-9BB76F5F-5666-4C07-8303-3669CC79128D
P2860
GENOPHAR: a randomized study of plasma drug measurements in association with genotypic resistance testing and expert advice to optimize therapy in patients failing antiretroviral therapy.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
GENOPHAR: a randomized study o ...... ailing antiretroviral therapy.
@en
GENOPHAR: a randomized study o ...... ailing antiretroviral therapy.
@nl
type
label
GENOPHAR: a randomized study o ...... ailing antiretroviral therapy.
@en
GENOPHAR: a randomized study o ...... ailing antiretroviral therapy.
@nl
prefLabel
GENOPHAR: a randomized study o ...... ailing antiretroviral therapy.
@en
GENOPHAR: a randomized study o ...... ailing antiretroviral therapy.
@nl
P2093
P2860
P50
P1433
P1476
GENOPHAR: a randomized study o ...... ailing antiretroviral therapy.
@en
P2093
Ait-Mohand H
Bonmarchand M
Bricaire F
Delaugerre C
P2860
P304
P356
10.1111/J.1468-1293.2004.00234.X
P577
2004-09-01T00:00:00Z